Literature DB >> 22540264

The rs150311303 polymorphism in FcγRIIa enhances IgG binding capacity.

A H Omar1, H Shibata, M Yasunami, A Yamazaki, M F Ofori, B D Akanmori, M N Shuaibu, M Kikuchi, K Hirayama.   

Abstract

Fc gamma receptor (FcγR) provides an important link between humoral and cellular immune responses. FcγRIIa-H131R polymorphism has been associated with differential binding to IgG subclasses and susceptibility to severe malaria phenotypes among different populations in the malaria endemic world. In this study, the effect of FCGR2A gene polymorphisms on susceptibility to symptomatic malaria among Ghanaian cohort children was investigated. Blood samples from four hundred and 29 (429) healthy Ghanaian children were genotyped for FCGR2A polymorphisms by direct DNA sequencing. Attributable and relative risks to symptomatic malaria were calculated for the polymorphic variants. Two major FCGR2A polymorphisms, rs1801274A/G (FcγRIIa-H131R) and rs150311303 (FcγRIIa-ins170L), were identified in the study population, and assessment of their risks did not show significant association with susceptibility to symptomatic malaria. The functional significance of these polymorphisms was also examined by evaluating their binding abilities to IgG subclasses using flow cytometric analysis of HEK cells transfected with the FcγRIIa haplotype variants. The binding assay revealed the rs150311303, which was observed only among carriers of the FcγRIIa-131RR genotype for the rs1801274 to consistently enhance binding capacities to all IgG subclasses. Thus, of the three FcγRIIa haplotype variants observed in this study population, the FcγRIIa(RL) haplotype variant was observed to have the highest binding ability to IgG1, IgG3 and IgG4.
© 2012 The Authors. Scandinavian Journal of Immunology © 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540264     DOI: 10.1111/j.1365-3083.2012.02715.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant.

Authors:  Minoru Tada; Akiko Ishii-Watabe; Keiko Maekawa; Hiromi Fukushima-Uesaka; Kouichi Kurose; Takuo Suzuki; Nahoko Kaniwa; Jun-Ichi Sawada; Nana Kawasaki; Takako Eguchi Nakajima; Ken Kato; Yasuhide Yamada; Yasuhiro Shimada; Teruhiko Yoshida; Takashi Ura; Miyuki Saito; Kei Muro; Toshihiko Doi; Nozomu Fuse; Takayuki Yoshino; Atsushi Ohtsu; Nagahiro Saijo; Haruhiro Okuda; Tetsuya Hamaguchi; Yoshiro Saito; Yasuhiro Matsumura
Journal:  Immunogenetics       Date:  2012-08-18       Impact factor: 2.846

2.  FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease.

Authors:  Ho-Chang Kuo; Yu-Wen Hsu; Mei-Shin Wu; Peng Yeong Woon; Henry Sung-Ching Wong; Li-Jen Tsai; Ruo-Kai Lin; Sukhontip Klahan; Kai-Sheng Hsieh; Wei-Chiao Chang
Journal:  Mediators Inflamm       Date:  2015-05-18       Impact factor: 4.711

Review 3.  Genetic Variation in Low-To-Medium-Affinity Fcγ Receptors: Functional Consequences, Disease Associations, and Opportunities for Personalized Medicine.

Authors:  Sietse Q Nagelkerke; David E Schmidt; Masja de Haas; Taco W Kuijpers
Journal:  Front Immunol       Date:  2019-10-03       Impact factor: 7.561

4.  FCGRs Polymorphisms and Response to Trastuzumab in Patients With HER2-Positive Breast Cancer: Far From Predictive Value?

Authors:  Andrea Botticelli; Federica Mazzuca; Marina Borro; Eva Mazzotti; Marco La Torre; Adriana Bonifacino; Francesca Romana Ciabatta; Giovanna Gentile; Chiara Maddalena; Maurizio Simmaco; Paolo Marchetti
Journal:  World J Oncol       Date:  2015-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.